Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Oct 28;16(10):e0259492. doi: 10.1371/journal.pone.0259492

Correction: Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria

Florence O Bada, Nick Blok, Evaezi Okpokoro, Saswata Dutt, Christopher Akolo, Patrick Dakum, Alash’le Abimiku
PMCID: PMC8553159  PMID: 34710200

The affiliation for the fourth author is incorrect. Saswata Dutt is not affiliated with #5 but with #4:

Department of Prevention, Care and Treatment, Institute of Human Virology, Abuja, Nigeria

Reference

  • 1.Bada FO, Blok N, Okpokoro E, Dutt S, Akolo C, Dakum P, et al. (2020) Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria . PLoS ONE 15(12): e0241065. 10.1371/journal.pone.0241065 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES